What I increasingly see at my Biotech is more and more AI assisted drug candidates but no corresponding improvement in the capacity or ability to manufacture and scale them. I think it's a problem that groups like Anthropic will encounter in a few months/years and one that will annoye them a lot because it's not as simple as throwing more compute, people or money at it.